Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bio-Techne Corp - Common Stock (NQ:TECH)

63.23 -1.57 (-2.43%)
Streaming Delayed Price Updated: 12:23 PM EST, Feb 11, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Bio-Techne Corp - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For August 28, 2023 ↗
 
Via Benzinga
News headline image
Bio-Techne's Ex-Dividend Date Is Thursday, Here's What You Need To Know ↗
 
Via Benzinga
News headline image
Nurturing Growth: Bio-Techne Supports Investors with Growing Earnings ↗
 
Via Benzinga
News headline image
3 Biotech Stocks to Buy Before the Breakout ↗
Explosive growth and rapid innovation lie ahead for these three biotechnology stocks, making them the ones to watch. 
Via InvestorPlace
News headline image
This Favorable Sign Appears On Bio-Techne's Chart ↗
 
Via Benzinga
News headline image
What 4 Analyst Ratings Have To Say About Bio-Techne ↗
 
Via Benzinga
News headline image
Bio-Techne: Q3 Earnings Insights ↗
 
Via Benzinga
News headline image
Thursday Is Your Last Chance To Buy Bio-Techne Before The Dividend Payout ↗
 
Via Benzinga
News headline image
Bio-Techne's Acquisition of Lunaphore Expands Its Spatial Biology Offerings ↗
Bio-Techne Corporation (NASDAQ: TECH) has agreed to acquire Lunaphore Inc with  
Via Benzinga
News headline image
Lunaphore to Get Acquired by Bio-Techne
From Lunaphore
Via Business Wire
News headline image
Abcam Downgrade: Analyst Trims Expectations Amid Activist Investor Engagement and Potential Bid Anticipation ↗
RBC Capital Markets has downgraded Abcam PLC (NASDAQ: ABCM) from Outperform to Sector Perform with a price target of $22,  
Via Benzinga
News headline image
This Analyst With 83% Accuracy Rate Sees Around 11% Upside In Texas Roadhouse - Here Are 5 Stock Picks For Last Week From Wall Street's Most Accurate Analysts ↗
U.S stocks closed higher on Friday, with the Dow Jones jumping more than 500 points during the session. 
Via Benzinga
News headline image
Analyst Expectations for Bio-Techne's Future ↗
 
Via Benzinga
News headline image
Earnings Outlook For Bio-Techne ↗
 
Via Benzinga
News headline image
Bio-Techne: Q1 Earnings Insights ↗
Bio-Techne (NASDAQ:TECH) reported its Q1 earnings results on Tuesday, November 1, 2022 at 06:30 AM. Here's what investors need to know about the announcement. 
Via Benzinga
News headline image
7 Biotech Stocks That Could Cure Your Portfolio Woes ↗
If you want to revitalize your portfolio with some exciting opportunities, these biotech stocks to buy might fit the bill. 
Via InvestorPlace
News headline image
5 Cheapest Health Care Stocks You Should Think About ↗
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. 
Via Benzinga
News headline image
5 Health Care Stocks That Are Diving - And May Rally ↗
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. 
Via Benzinga
News headline image
5 Most Cheapest Stocks In The Healthcare Sector: Bio-Techne, Mirati Therapeutics And More ↗
The most oversold stocks in the healthcare sector presents an opportunity to buy into undervalued companies. 
Via Benzinga
News headline image
Our 7 Top Biotech Stock Picks for 2023 ↗
Following the devastation of Covid-19, there’s greater interest toward medical innovations, thus bolstering biotech stock picks for 2023. 
Via InvestorPlace
News headline image
Recap: Bio-Techne Q4 Earnings ↗
  Bio-Techne (NASDAQ:TECH) reported its Q4 earnings results on Thursday, August 4, 2022 at 06:30 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 10, 2023 ↗
 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 14, 2022 ↗
 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 12, 2022 ↗
 
Via Benzinga
News headline image
NexImmune Price Target Cut By 75%, Plus Wells Fargo Lowers PT Price Target On These Stocks ↗
Raymond James cut the price target for NexImmune, Inc. (NASDAQ: NEXI) from $12 to $3. NexImmune shares rose 2.4% to $1.29 in pre-market trading. 
Via Benzinga
News headline image
Earnings Scheduled For November 1, 2022 ↗
Companies Reporting Before The Bell • BP (NYSE:BP) is estimated to report quarterly earnings at $2.07 per share on revenue of $64.76 billion. 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Monday ↗
  On Monday, 429 stocks made new 52-week lows. 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Friday ↗
  During Friday's session, 574 stocks hit new 52-week lows. 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Wednesday ↗
  During Wednesday's session, 265 companies made new 52-week lows. 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For August 25, 2022 ↗
Upgrades 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.